AngioDynamics (ANGO) Tops Q4 EPS by 11c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $12.32 +5.03%
Financial Fact:
Interest expense: -723K
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Interest expense: -723K
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
AngioDynamics (NASDAQ: ANGO) reported Q4 EPS of ($0.05), $0.10 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $70.98 million versus the consensus estimate of $70.9 million.
GUIDANCE:
AngioDynamics sees FY2025 EPS of ($0.38)-($0.42), versus the consensus of ($0.52). AngioDynamics sees FY2025 revenue of $282-288 million, versus the consensus of $292.7 million.
For earnings history and earnings-related data on AngioDynamics (ANGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Airbnb (ABNB) call put ratio 1 call to 1.3 puts into quarter results
- Qualcomm stock climbs after SpaceX 5G network deal
- Netflix gains after Ackman endorsement and AI feature launch
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
